Status:

COMPLETED

Medical Abortion up to 10 Weeks Gestation at Home

Lead Sponsor:

Karolinska Institutet

Conditions:

Pregnancy Complications

Legally Induced Abortion Without Mention of Complication

Eligibility:

FEMALE

18+ years

Brief Summary

Medical abortion performed in the womens home has shown to be safe and acceptable up to 9 weeks of gestation. Our project is aiming to confirm our hypothesis that it is equally effective, safe and acc...

Detailed Description

The study will include 600 women opting for medical abortion. Women wanting to perform the last part of the abortion in their homes will be invited to participate. 300 women with a pregnancy up to 9 w...

Eligibility Criteria

Inclusion

  • Healthy
  • Requesting and eligible for medical abortion
  • Confirmed intrauterine pregnancy
  • Gestational length no more than 70 days
  • Hemoglobin over 100g/l

Exclusion

  • Anemia
  • Contraindication to mifepristone (steroid-dependant cancer, porphyria)
  • Breast feeding
  • Advanced pregnancy (\>70 days)
  • Known liver disease
  • Bleeding disorder
  • Arterial hypertension

Key Trial Info

Start Date :

September 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2021

Estimated Enrollment :

273 Patients enrolled

Trial Details

Trial ID

NCT02191774

Start Date

September 1 2014

End Date

December 1 2021

Last Update

June 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Södersjukhuset

Stockholm, Sweden, 118 83